Research Project: PMH-Regulator® is an effective and safe treatment for premenopausal
and menopausal symptoms

In 2010, the Max Biocare Institute collaborated with Hanoi Medical University in Vietnam on a clinical trial of PMH-Regulator® for the treatment of pre-menopausal and menopausal symptoms.

PMH-Regulator® is a TGA listed formulation consisting of 2 active ingredients: isoflavones (from glycine max seed) and chasteberry fruit. Each PMH-Regulator® capsule contains extracts equivalent to dry glycine max seed 32g (equivalent to isoflavones 80mg) and vitex agnus-castus (chasteberry) fruit 200mg.

A total of 77 pre-menopausal and menopausal women in Hanoi and Hai Phong were enrolled and administered 1 capsule of PMH-Regulator® on a daily basis for 3 consecutive months. The researchers found a statistically significant reduction in the frequency and severity of pre-menopausal and menopausal symptoms. After the treatment, fewer women experienced vasomotor symptoms (i.e. hot flushes, night sweats, chills and palpitations), and neurological symptoms (i.e. headaches, concentration difficulties). In addition, improvements in urogenital-vaginal symptoms (i.e. vaginal dryness, pain during intercourse, urogenital infection) was observed.

The results were disseminated in a local medical journal in the Vietnamese language